Skin dose contamination conversion coefficients. Benchmark with three simulation codes.

Handling of radioactive material by operators can lead to contamination at the surface of the skin in case of an accident. The quantification of the dose received by the skin due to a contamination scenario is performed by means of dedicated dose coefficients as it is the case for other radiation protection dose quantities described in the literature. However, most available coefficients do not match realistic scenarios according to state-of-the-art of science and technology. Therefore, this work deals with dedicated dose conversion factors for skin contamination. Since there is an increasing demand on dose coefficients in general, these specific coefficients can be used for various calculations in radiation protection. In this work a method to evaluate such coefficients for the skin contamination dose related to photons, electrons, positrons, alpha and neutron particles is proposed. The coefficients are generated using Monte-Carlo simulations with three well established calculation codes (FLUKA, MCNP, and GEANT4). The results of the various codes are compared against each other for benchmarking purposes. The new dose coefficients allow the computation of the skin received dose, in the case of skin contamination scenario of an individual, taking into account the decay radiation of the radionuclides of interest. To benchmark the quantity derived here, comparisons of radionuclide contamination doses to the skin using the VARSKIN code available in the literature are performed with the results of this work.

CERN-MEDICIS: A Review Since Commissioning in 2017.

The CERN-MEDICIS (MEDical Isotopes Collected from ISolde) facility has delivered its first radioactive ion beam at CERN (Switzerland) in December 2017 to support the research and development in nuclear medicine using non-conventional radionuclides. Since then, fourteen institutes, including CERN, have joined the collaboration to drive the scientific program of this unique installation and evaluate the needs of the community to improve the research in imaging, diagnostics, radiation therapy and personalized medicine. The facility has been built as an extension of the ISOLDE (Isotope Separator On Line DEvice) facility at CERN. Handling of open radioisotope sources is made possible thanks to its Radiological Controlled Area and laboratory. Targets are being irradiated by the 1.4 GeV proton beam delivered by the CERN Proton Synchrotron Booster (PSB) on a station placed between the High Resolution Separator (HRS) ISOLDE target station and its beam dump. Irradiated target materials are also received from external institutes to undergo mass separation at CERN-MEDICIS. All targets are handled via a remote handling system and exploited on a dedicated isotope separator beamline. To allow for the release and collection of a specific radionuclide of medical interest, each target is heated to temperatures of up to 2,300°C. The created ions are extracted and accelerated to an energy up to 60 kV, and the beam steered through an off-line sector field magnet mass separator. This is followed by the extraction of the radionuclide of interest through mass separation and its subsequent implantation into a collection foil. In addition, the MELISSA (MEDICIS Laser Ion Source Setup At CERN) laser laboratory, in service since April 2019, helps to increase the separation efficiency and the selectivity. After collection, the implanted radionuclides are dispatched to the biomedical research centers, participating in the CERN-MEDICIS collaboration, for Research & Development in imaging or treatment. Since its commissioning, the CERN-MEDICIS facility has provided its partner institutes with non-conventional medical radionuclides such as Tb-149, Tb-152, Tb-155, Sm-153, Tm-165, Tm-167, Er-169, Yb-175, and Ac-225 with a high specific activity. This article provides a review of the achievements and milestones of CERN-MEDICIS since it has produced its first radioactive isotope in December 2017, with a special focus on its most recent operation in 2020.

Photons fluence to local skin Dose coefficients and benchmark with three Monte-Carlo codes. Application to the computation of radioactive material transport limits.

Fluence to Local Skin Dose Conversion Coefficients (LSD-CC) are radiological protection quantities used for external radiation exposures which allow the conversion of particle fluences into local skin equivalent dose. The International Commission on Radiological Protection published LSD-CC for electrons with an energy range from 10 keV to 10 MeV. However, the literature does not address these radiation protection quantities for all particle types, in particular for photons. In this article, computed LSD-CC values for photons are presented which enrich the literature and are of interest for the radiation protection community. As an example for an application of the use of the computed LSD-CC values, the IAEA A1/A2 working group, which supports the review of the international regulation related to the transport of radioactive material, has decided to estimate the dose to the skin using such coefficients. In this publication, LSD-CC for photons are computed and benchmarked using GEANT4, FLUKA and MCNP. In addition, the FLUKA Monte-Carlo calculation code is used to compute the LSD-CC values for electrons and positrons to compare with existing data in the literature and validate the presented models. As one application of these LSD-CC values, the transfer functions for calculating the IAEA A-values are determined using the LSD-CC and are compared to a one-step direct calculation method.

Calculation and benchmark of fluence-to-local skin equivalent dose coefficients for neutrons with FLUKA, MCNP, and GEANT4 Monte-Carlo codes.

Dose equivalent limits for single organs are recommended by the ICRP (International Commission for the Radiological Protection publication 103). These limits do not lend themselves to be measured. They are assessed by convoluting conversion factors with particle fluences. The Fluence-to-Dose conversion factors are tabulated in the ICRP literature. They allow assessing the organ dose of interest using numerical simulations. In particular, the literature lacks the knowledge of local skin equivalent dose (LSD) coefficients for neutrons. In this article, we compute such values for neutron energies ranging from 1 meV to 15 MeV. We use FLUKA, MCNP and GEANT4 Radiation transport Monte-Carlo simulation codes to perform the calculations. A comparison between these three codes is performed. These calculated values are important for radiation protection studies and radiotherapy applications.

An enhanced characterization process for the elimination of very low level radioactive waste in particle accelerators.

The elimination of very low level waste towards the French national repository requires their radiological characterization to estimate the radionuclide inventory and the associated activities within a waste package. Such characterization is performed by means of activation calculations and measurements. Two elimination projects have been identified at CERN, to dispose of bulk metallic waste and cables activated in the CERN accelerator complex. Based on the experience gained over the last 4 years, we develop a large scale elimination process to dispose of such types of activated equipment. A program for quality controls has therefore been developed through a novel software tool whose purpose is to compute the radiological data required by the repository for the acceptance of the waste as well as performing quality controls.

A novel technique for the optimization and reduction of gamma spectroscopy geometry uncertainties.

Material activation can sometimes cause large heterogeneities in the distribution of radioactivity (hotspots). Moreover, the sample geometry parameters are not always well known. When performing gamma-spectroscopy to quantify the radionuclide inventory in activated materials, often predefined models are used to represent the sample geometry (dimensions, source-to-detector distance, material type) and their activity distribution, for efficiency calibration. This simplification causes uncertainties of the efficiency curves associated with the model and consequently, to the activity results. In this paper, we develop a new approach, based on ISOCS/LabSOCS to quantify and reduce uncertainties originating from the geometry model. The theory is described in this document and an experimental case is discussed.

Spectrum and Yield to Dose Conversion Coefficients for Beta Skin Doses Linked to the Q System.

Monte Carlo simulations are a state-of-the-art method to calculate dose coefficients and could be used with the Q system for radioactive material packaging. These simulations often take a long time to converge with sufficient precision. Furthermore, if multiple sources have to be taken into account, many weeks of calculations may be needed. In order to reduce the calculation time, this paper proposes a new method based on a transfer function to instantly compute Q values associated with beta skin doses. The method developed in this paper can be applied to compute beta skin dose and easily could be extended to other particles and different depths in organs with various kinds of shielding configurations between source and target.